![Jun Yoon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jun Yoon
Gründer bei
STRUCTURE THERAPEUTICS INC.
Vermögen: 43 Mio $ am 31.07.2026
Profil
Jun Yoon is the founder of Structure Therapeutics, Inc., founded in 2019, serving as Chief Financial Officer.
Mr. Yoon currently works at Shanghai ShouTi Biotechnology Co. Ltd. as Chief Operating Officer & Director.
Former jobs include Senior Director-Licensing & Business Development at VIA Pharmaceuticals, Inc. from 2004 to 2010, Head-Business Development at Syrrx, Inc. from 2000 to 2002, and Vice President-Corporate Development at Cellerant Therapeutics, Inc. from 2010 to 2016.
Education includes undergraduate studies at the University of California.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 2.683.830 ( 1,92 % ) | 43 Mio $ | 31.07.2026 |
Aktive Positionen von Jun Yoon
| Unternehmen | Position | Beginn |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Gründer | 01.02.2019 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Geschäftsführer | - |
Ehemalige bekannte Positionen von Jun Yoon
| Unternehmen | Position | Ende |
|---|---|---|
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Corporate Officer/Principal | 01.01.2016 |
| VIA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2010 |
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Corporate Officer/Principal | 01.10.2002 |
Ausbildung von Jun Yoon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
50
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Health Technology |
VIA Pharmaceuticals, Inc.
 VIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops compounds for the treatment of cardiovascular and metabolic disease | Health Technology |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
